Industry / Brazil
Biodiversity Bill To Favour Transparent R&D
March 2008 | Industry NewsIn an attempt to remedy long-running concerns over the control of bioprospecting, Brazil is set to overhaul the regulation of the way firms use the country's biodiversity to develop pharmaceuticals. The new bill - Access to Genetic Resources, Traditional Knowledge and Sharing Benefits - will be open to public consultation until April
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
